Personality
7
Open
7
Cons
6
Extr
6
Agre
3
Neur
Pfizer
Healthcare · Mid Cap
Mature Stable · Hierarchical
About
Meenakshi Nevatia is the Managing Director of Pfizer, a Mid Cap company in the Healthcare sector with a market cap of ₹22K Cr. A Visionary leader with 31 years of experience, she is known for data-driven decision-making and organic builder strategy. Focuses on portfolio diversification and leveraging global R&D pipelines for the local Indian market.
FAQ
What is Meenakshi Nevatia's leadership style?
Meenakshi Nevatia is classified as a Visionary leader. She is data-driven in decision-making, with a category creator motivation and steady-marathon pace of execution.
What is Meenakshi Nevatia's educational background?
Meenakshi Nevatia holds a Bachelor of Science in Economics and Mathematics from Presidency College, Kolkata and a MBA in Strategy and Finance from IIM Ahmedabad.
Who is the CEO of Pfizer?
Meenakshi Nevatia is the Managing Director of Pfizer. She has been with the company for 5 years and in the current role for 5 years.
Leadership DNA
ArchetypeVisionary
MotivationCategory Creator
CrisisSteady Hand
DecisionData-Driven
GrowthOrganic Builder
PeopleNumbers Driven
InnovationFast-Follower
PaceSteady-Marathon
PurposePurpose-Blended
CustomerB2G-Institutional
EmployerSteady Employer
BrandTrusted
FocusProduct Innovation
OrientationDeep Specialist
Leadership Evidence
“Focuses on portfolio diversification and leveraging global R&D pipelines for the local Indian market.”
⚡ Crisis●●●○○
As MD of Pfizer India, she has focused on maintaining supply chain continuity and portfolio stability during post-pandemic market volatility.
🎯 Motivation●●●○○
She has consistently prioritized the introduction of innovative, high-science therapeutic solutions to address unmet medical needs in the Indian market.
👥 People●●●●○
Her leadership style is defined by a data-driven approach to market penetration and rigorous performance management aligned with global Pfizer metrics.
📈 Growth●●●●○
Her strategy centers on deepening the penetration of Pfizer's existing premium portfolio through operational excellence and digital transformation.
💡 Innovation●●●●○
As an Indian subsidiary, it focuses on localizing and scaling the global Pfizer portfolio rather than pioneering original drug discovery in-house.
🏃 Pace●●●●●
Operates with a highly regulated, process-driven rhythm characteristic of the multinational pharmaceutical sector in India.
🌱 Purpose●●●●○
The company maintains a strong focus on public health awareness campaigns and CSR initiatives aligned with its global 'Patient First' strategy.
🏷️ Brand●●●●●
The brand is synonymous with medical safety, clinical rigor, and decades of reliability in the Indian healthcare market.
🤝 Customer●●●●○
The business model relies heavily on institutional sales, medical professional advocacy, and government-tendered healthcare procurement.
💼 Employer●●●●○
Pfizer India is widely recognized for offering a stable, structured, and long-term career path with high institutional prestige.
📋 Mandate
The company must pivot its portfolio toward high-growth therapeutic segments to counter the maturity of legacy product lines.
🏢 Culture●●●●○
Follows a structured global corporate hierarchy and professional management protocols inherent in a large, stable, MNC-subsidiary pharmaceutical environment.
Financials
Revenue FY25₹2K Cr
PAT FY25₹768 Cr
Rev CAGR 5Y-4.4%
OPM29.9%
NPM33.7%
ROE18.2%
ROCE15.7%
P/E24.8
Fwd P/E24.4
P/B5.5
D/E2.3
Promoter67%
Institutional18%
Mkt Cap₹22K Cr
Compensation
To Be Published
Data being verified from audited reports
